© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Tyra Biosciences, Inc. (TYRA) stock declined over -1.01%, trading at $15.75 on NASDAQ, down from the previous close of $15.91. The stock opened at $15.70, fluctuating between $15.24 and $16.05 in the recent session.
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.
Employees | 49 |
Beta | 1.08 |
Sales or Revenue | $0.00 |
5Y Sales Change% | 0% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |
Tyra Biosciences, Inc. (NASDAQ: TYRA) stock price is $15.75 in the last trading session. During the trading session, TYRA stock reached the peak price of $16.05 while $15.24 was the lowest point it dropped to. The percentage change in TYRA stock occurred in the recent session was -1.01% while the dollar amount for the price change in TYRA stock was -$0.16.
The NASDAQ listed TYRA is part of Biotechnology industry that operates in the broader Healthcare sector. Tyra Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Lynn Scherm
Fin. Director
Dr. Piyush R. Patel Ph.D.
Chief Devel. Officer
Mr. Alan Fuhrman
Chief Financial Officer
Dr. Todd Harris Ph.D.
Co-Founder, Pres, Chief Executive Officer, Sec., Treasurer & Director
Amy Conrad
Investor Contact
Dr. Robert L. Hudkins Ph.D.
Chief Technology Officer
Mr. Ali D. Fawaz J.D.
Gen. Counsel & Sec.
Dr. Ronald V. Swanson Ph.D.
Chief Scientific Officer
Dr. Hiroomi Tada M.D., Ph.D.
Chief Medical Officer
Mr. Daniel Bensen
Co-Founder & Chief Operating Officer
Ms. Esther van den Boom CPA, CPA
Chief Financial Officer
Ms. Sarah Honig
Vice President of Corporation Devel. & Strategy
Tonya Blizzard
Associate Director of Accounting
TYRA's closing price is 28.93% higher than its 52-week low of $12.34 where as its distance from 52-week high of $29.60 is -46.25%.
Number of TYRA employees currently stands at 49.
Official Website of TYRA is: https://www.tyra.bio
TYRA could be contacted at phone 619 728 4760 and can also be accessed through its website. TYRA operates from 2656 State Street, Carlsbad, CA 92008, United States.
TYRA stock volume for the day was 134.59K shares. The average number of TYRA shares traded daily for last 3 months was 361.69K.
The market value of TYRA currently stands at $832.73M with its latest stock price at $15.75 and 52.87M of its shares outstanding.